Physician profile
Karl R Stark
NPI 1699744961
$223,211.22
in general payments reported to CMS, 2019-2025
37 companies · $37K in 2025
The $37K reported for 2025 was more than what 97% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $3,118 · 2021: $2,540 · 2022: $25K · 2023: $67K · 2024: $74K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $130K · Travel and Lodging: $36K · Food and Beverage: $5,382 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,699 · Consulting Fee: $2,450 · Education: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $130,437.50 |
| Travel and Lodging | $35,679.26 |
| Food and Beverage | $5,382.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,699.00 |
| Consulting Fee | $2,450.00 |
| Education | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $203,998.86 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Bard Peripheral Vascular, INC. | $11,210.56 | 2019-2021 | |
| Endologix LLC | $2,126.21 | 2020-2024 | |
| Medtronic Vascular, INC. | $1,877.54 | 2019-2020 | |
| Medtronic, INC. | $838.56 | 2021-2023 | Endurant Iis |
| Inari Medical, INC. | $528.80 | 2019-2022 | |
| Lemaitre Vascular, INC. | $316.83 | 2019-2023 | Hydro Lemaitre Valvulotome |
| Veryan Medical Incorporated | $253.43 | 2021 | |
| Becton, Dickinson and Company | $202.58 | 2019-2020 | |
| Boston Scientific Corporation | $175.24 | 2019 | |
| Silk Road Medical, INC. | $170.92 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $155.50 | 2019-2020 | |
| Angiodynamics, INC. | $154.10 | 2021-2022 | |
| Penumbra, INC. | $153.10 | 2020-2021 | |
| Cook Medical LLC | $151.66 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $147.81 | 2020 | |
| Aroa Biosurgery Incorporated | $121.28 | 2023 | |
| Misonix INC | $110.18 | 2019 | |
| Organogenesis INC. | $84.17 | 2020-2021 | |
| Baxter Healthcare | $54.34 | 2019 | |
| Bolton Medical INC | $54.27 | 2019 | |
| Smith+Nephew, INC. | $37.68 | 2019 | |
| Cordis US Corp. | $31.46 | 2023 | Brite Tip Radianz |
| Medline Industries Lp | $29.89 | 2019 | |
| Artivion, INC. | $28.45 | 2019 | |
| Covidien Lp | $27.45 | 2019 | |
| Acell, INC. | $24.84 | 2020 | |
| Terumo Cardiovascular Systems Corporation | $19.54 | 2019 | |
| Acera Surgical, INC. | $19.12 | 2019 | |
| W. L. Gore & Associates, INC. | $17.49 | 2019 | |
| Kci USA, INC. | $17.17 | 2019 | |
| Bsn Medical INC | $15.07 | 2019 | |
| Cardinal Health 200 LLC | $12.93 | 2019 | |
| Melinta Therapeutics, LLC | $12.16 | 2019 | |
| Osiris Therapeutics INC. | $11.70 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.25 | 2019 | |
| Z-Medica, LLC | $9.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Stark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.